Chronic lymphocytic leukemia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
In 2011, the age-adjusted [[incidence]] of chronic lymphocytic leukemia (CLL) was 4.82 per 100,000 persons in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>  [[CLL]] is a disease of the elderly and is rarely encountered in individuals under the age of 40.  Most (>75%) people newly diagnosed with CLL are over age 50.  Thereafter the disease incidence increases with age.
==Epidemiology and Demographics==
===Prevalence===
The [[prevalence]] of CLL ranges from a low of 10 per 100,000 patients, to a high of 50 per 100,000 patients with an average prevalence of 30 per 100,000 patients.


==Epidemiology and demographics==
===Incidence===
===Incidence===
The [[incidence]] of CLL in developed countries is 4 per 100,000. It increases to more than 30 per 100,000 at age 80 yrs.
* The [[incidence]] of CLL in developed countries is 4 per 100,000. It increases to more than 30 per 100,000 at age 80 yrs.


===Prevalence===
* In 2011, the age-adjusted [[incidence]] of CLL was 4.82 per 100,000 persons in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
The [[prevalence]] of CLL ranges from a low of 10 per 100,000 patients, to a high of 50 per 100,000 patients with an average prevalence of 30 per 100,000 patients.


===Age===
===Age===
[[CLL]] is a disease of the elderly and is rarely encountered in individuals under the age of 40.  Most (>75%) people newly diagnosed with CLL are over age 50.  Thereafter the disease incidence increases with age.  Of note, subclinical "disease" can be identified in up to 7-8% of individuals over the age of 70.  That is, small clones of B cells with the characteristic CLL phenotype can be identified in many healthy elderly persons.  The clinical significance of these cells is unknown.
* [[CLL]] is a disease of the elderly and is rarely encountered in individuals under the age of 40.  Most (>75%) people newly diagnosed with CLL are over age 50.  Thereafter the disease incidence increases with age.  Of note, subclinical "disease" can be identified in up to 7-8% of individuals over the age of 70.  That is, small clones of B cells with the characteristic CLL phenotype can be identified in many healthy elderly persons.  The clinical significance of these cells is unknown.
 
* While the overall age-adjusted [[incidence]] of CLL in the United States between 2007 and 2011 is 4.4 per 100,000, the age-adjusted [[incidence]] of CLL by age category is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
** Under 65 years: 1.4 per 100,000
** 65 and over: 25.2 per 100,000


===Gender===
===Gender===
[[CLL]] is more common in men.  Two thirds of the patients are men.
* [[CLL]] is more common in men.  Two thirds of the patients are men.
* In the United States, the age-adjusted [[incidence]] of CLL by gender on 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
** In males: 6.44 per 100,000 persons
** In females: 3.51 per 100,000 persons


===Race===
===Race===

Revision as of 18:02, 12 June 2014

Chronic lymphocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic lymphocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic lymphocytic leukemia epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic lymphocytic leukemia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic lymphocytic leukemia epidemiology and demographics

CDC on Chronic lymphocytic leukemia epidemiology and demographics

Chronic lymphocytic leukemia epidemiology and demographics in the news

Blogs on Chronic lymphocytic leukemia epidemiology and demographics

Directions to Hospitals Treating Chronic lymphocytic leukemia

Risk calculators and risk factors for Chronic lymphocytic leukemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

In 2011, the age-adjusted incidence of chronic lymphocytic leukemia (CLL) was 4.82 per 100,000 persons in the United States.[1] CLL is a disease of the elderly and is rarely encountered in individuals under the age of 40. Most (>75%) people newly diagnosed with CLL are over age 50. Thereafter the disease incidence increases with age.

Epidemiology and Demographics

Prevalence

The prevalence of CLL ranges from a low of 10 per 100,000 patients, to a high of 50 per 100,000 patients with an average prevalence of 30 per 100,000 patients.

Incidence

  • The incidence of CLL in developed countries is 4 per 100,000. It increases to more than 30 per 100,000 at age 80 yrs.
  • In 2011, the age-adjusted incidence of CLL was 4.82 per 100,000 persons in the United States.[1]

Age

  • CLL is a disease of the elderly and is rarely encountered in individuals under the age of 40. Most (>75%) people newly diagnosed with CLL are over age 50. Thereafter the disease incidence increases with age. Of note, subclinical "disease" can be identified in up to 7-8% of individuals over the age of 70. That is, small clones of B cells with the characteristic CLL phenotype can be identified in many healthy elderly persons. The clinical significance of these cells is unknown.
  • While the overall age-adjusted incidence of CLL in the United States between 2007 and 2011 is 4.4 per 100,000, the age-adjusted incidence of CLL by age category is:[1]
    • Under 65 years: 1.4 per 100,000
    • 65 and over: 25.2 per 100,000

Gender

  • CLL is more common in men. Two thirds of the patients are men.
  • In the United States, the age-adjusted incidence of CLL by gender on 2011 is:[1]
    • In males: 6.44 per 100,000 persons
    • In females: 3.51 per 100,000 persons

Race

CLL is common in the white race compared to the black race.

References

  1. 1.0 1.1 1.2 1.3 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Template:Hematology


Template:WikiDoc Sources